Japanese company profile · 7096

StemCell Institute Inc.

In its FY2025 public filing, StemCell Institute Inc. reports Cell banks. The page shows business-level revenue and profit where the source disclosures support comparison.

Original Japanese company name: 株式会社ステムセル研究所

English company name recorded in Japan's EDINET filer data. English company name source

Reported company-wide figures

Company revenue
¥2.81B ↗
FY2025 · fiscal year ended March 2026
Company profit
¥202.66M ↗
FY2025 · fiscal year ended March 2026
Profit margin
7.2% ↗
FY2025 · fiscal year ended March 2026

What does this company do?

What does this company do?

StemCell Institute Inc.'s largest reported business by revenue in FY2025 was Cell banks.

The business with the highest reported segment profit in FY2025 was Cell banks.

FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.

Business structure

How does it make money?

BusinessSalesRevenue shareOperating profit
Cell banks¥2.81B ↗100.0%¥202.66M ↗

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.

Original Japanese label
Cell banks
細胞バンク事業
Sales
売上高
Operating profit
営業利益
Original Japanese label
Cell banks
細胞バンク事業
Sales
売上高
Operating profit
営業利益

What is growing?

What is growing?

No comparable reported revenue growth is available.

What has changed?

What has changed?

Not disclosed or not safely comparable in the available filings.

Source

Public filing

FY2025 · fiscal year ended March 2026

The source document may be in Japanese.

Filing ID: S100YI32

View original filing ↗

Ask about this company

Ask about this company

The source document may be in Japanese.

根拠となる資料